Feb 4 (Reuters) - Industrial equipment maker IDEX Corp IEX.N reported a better-than-expected quarterly profit on Tuesday, driven by strong sales of its health and science technology segment products.
Quarterly sales in IDEX's health and sciences technology segment, which includes components and equipment used in clinical diagnostics and drug discovery, as well as in the food processing and cosmetic manufacturing industries, rose 19.3%.
The rise in demand was led by sellers seeking to replenish inventories following an extended destocking cycle triggered by large stockpiles during the COVID-19 pandemic.
Quarterly adjusted earnings per share stood at $2.04, compared with Wall Street estimates of $2.02, according to data compiled by LSEG.
Total revenue for the fourth quarter ended Dec. 31 was $862.9 million, up about 9% from a year earlier. Analysts, on average, were expecting revenue of $863.8 million in the fourth quarter.
(Reporting by Aishwarya Jain and Nathan Gomes; Editing by Mohammed Safi Shamsi)
((Aishwarya.Jain@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.